A short review on antibody therapy for COVID-19.
Identifieur interne : 001969 ( Main/Exploration ); précédent : 001968; suivant : 001970A short review on antibody therapy for COVID-19.
Auteurs : G. Venkat Kumar [Inde] ; V. Jeyanthi [Inde] ; S. Ramakrishnan [États-Unis]Source :
- New microbes and new infections [ 2052-2975 ] ; 2020.
Abstract
The beginning of the novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To date, the anti-malaria drug hydroxychloroquine found to be a treatment option for SARS-CoV-2. In addition to supportive treatment, such as oxygen supply in moderate cases and extracorporeal membrane oxygenation in critically ill patients, unique medications for this condition are also under investigation. Here we reviewed the antibody therapy might be an immediate strategy for emergency prophylaxis and SARS-CoV-2 therapy.
DOI: 10.1016/j.nmni.2020.100682
PubMed: 32313660
PubMed Central: PMC7167584
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A short review on antibody therapy for COVID-19.</title><author><name sortKey="Venkat Kumar, G" sort="Venkat Kumar, G" uniqKey="Venkat Kumar G" first="G" last="Venkat Kumar">G. Venkat Kumar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology, Ponnaiyah Ramajayam Institute of Science and Technology, Thanjavur, 613403, Tamil Nadu, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Biotechnology, Ponnaiyah Ramajayam Institute of Science and Technology, Thanjavur, 613403, Tamil Nadu</wicri:regionArea><wicri:noRegion>Tamil Nadu</wicri:noRegion></affiliation></author><author><name sortKey="Jeyanthi, V" sort="Jeyanthi, V" uniqKey="Jeyanthi V" first="V" last="Jeyanthi">V. Jeyanthi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology, SRM Arts and Science College, Kattankulathur, Chengalpattu District, 603203, Tamil Nadu, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Biotechnology, SRM Arts and Science College, Kattankulathur, Chengalpattu District, 603203, Tamil Nadu</wicri:regionArea><wicri:noRegion>Tamil Nadu</wicri:noRegion></affiliation></author><author><name sortKey="Ramakrishnan, S" sort="Ramakrishnan, S" uniqKey="Ramakrishnan S" first="S" last="Ramakrishnan">S. Ramakrishnan</name><affiliation wicri:level="2"><nlm:affiliation>Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32313660</idno><idno type="pmid">32313660</idno><idno type="doi">10.1016/j.nmni.2020.100682</idno><idno type="pmc">PMC7167584</idno><idno type="wicri:Area/Main/Corpus">001936</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001936</idno><idno type="wicri:Area/Main/Curation">001936</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001936</idno><idno type="wicri:Area/Main/Exploration">001936</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A short review on antibody therapy for COVID-19.</title><author><name sortKey="Venkat Kumar, G" sort="Venkat Kumar, G" uniqKey="Venkat Kumar G" first="G" last="Venkat Kumar">G. Venkat Kumar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology, Ponnaiyah Ramajayam Institute of Science and Technology, Thanjavur, 613403, Tamil Nadu, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Biotechnology, Ponnaiyah Ramajayam Institute of Science and Technology, Thanjavur, 613403, Tamil Nadu</wicri:regionArea><wicri:noRegion>Tamil Nadu</wicri:noRegion></affiliation></author><author><name sortKey="Jeyanthi, V" sort="Jeyanthi, V" uniqKey="Jeyanthi V" first="V" last="Jeyanthi">V. Jeyanthi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology, SRM Arts and Science College, Kattankulathur, Chengalpattu District, 603203, Tamil Nadu, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Biotechnology, SRM Arts and Science College, Kattankulathur, Chengalpattu District, 603203, Tamil Nadu</wicri:regionArea><wicri:noRegion>Tamil Nadu</wicri:noRegion></affiliation></author><author><name sortKey="Ramakrishnan, S" sort="Ramakrishnan, S" uniqKey="Ramakrishnan S" first="S" last="Ramakrishnan">S. Ramakrishnan</name><affiliation wicri:level="2"><nlm:affiliation>Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author></analytic><series><title level="j">New microbes and new infections</title><idno type="ISSN">2052-2975</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The beginning of the novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To date, the anti-malaria drug hydroxychloroquine found to be a treatment option for SARS-CoV-2. In addition to supportive treatment, such as oxygen supply in moderate cases and extracorporeal membrane oxygenation in critically ill patients, unique medications for this condition are also under investigation. Here we reviewed the antibody therapy might be an immediate strategy for emergency prophylaxis and SARS-CoV-2 therapy.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32313660</PMID><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2052-2975</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>New microbes and new infections</Title><ISOAbbreviation>New Microbes New Infect</ISOAbbreviation></Journal><ArticleTitle>A short review on antibody therapy for COVID-19.</ArticleTitle><Pagination><MedlinePgn>100682</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nmni.2020.100682</ELocationID><Abstract><AbstractText>The beginning of the novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To date, the anti-malaria drug hydroxychloroquine found to be a treatment option for SARS-CoV-2. In addition to supportive treatment, such as oxygen supply in moderate cases and extracorporeal membrane oxygenation in critically ill patients, unique medications for this condition are also under investigation. Here we reviewed the antibody therapy might be an immediate strategy for emergency prophylaxis and SARS-CoV-2 therapy.</AbstractText><CopyrightInformation>© 2020 Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Venkat Kumar</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Ponnaiyah Ramajayam Institute of Science and Technology, Thanjavur, 613403, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeyanthi</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, SRM Arts and Science College, Kattankulathur, Chengalpattu District, 603203, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishnan</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>New Microbes New Infect</MedlineTA><NlmUniqueID>101624750</NlmUniqueID><ISSNLinking>2052-2975</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Convalescent plasma therapy</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">monoclonal antibody therapy</Keyword><Keyword MajorTopicYN="N">receptor binding domain</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32313660</ArticleId><ArticleId IdType="doi">10.1016/j.nmni.2020.100682</ArticleId><ArticleId IdType="pii">S2052-2975(20)30034-2</ArticleId><ArticleId IdType="pii">100682</ArticleId><ArticleId IdType="pmc">PMC7167584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation><ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Emerg Med. 2019 Dec;37(12):2264.e5-2264.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">31477360</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Anesthesiol. 2016 Jul 12;16(1):36</Citation><ArticleIdList><ArticleId IdType="pubmed">27405596</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2020 Mar 17;94(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">31996437</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2015 Sep 03;13:210</Citation><ArticleIdList><ArticleId IdType="pubmed">26336062</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Aust. 2020 Mar 17;:MA20013</Citation><ArticleIdList><ArticleId IdType="pubmed">32226946</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatol. 2019 Aug;71(2):434-438</Citation><ArticleIdList><ArticleId IdType="pubmed">31075322</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2020 Mar 27;11(1):1620</Citation><ArticleIdList><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation><ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):382-385</Citation><ArticleIdList><ArticleId IdType="pubmed">32065055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation><ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15616839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil Med Res. 2020 Mar 13;7(1):11</Citation><ArticleIdList><ArticleId IdType="pubmed">32169119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2020 Apr;26(4):450-452</Citation><ArticleIdList><ArticleId IdType="pubmed">32284615</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Feb;79(3):1635-44</Citation><ArticleIdList><ArticleId IdType="pubmed">15650189</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2019 May 27;16(1):69</Citation><ArticleIdList><ArticleId IdType="pubmed">31133031</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2020 May 14;11(1):2511</Citation><ArticleIdList><ArticleId IdType="pubmed">32409714</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Apr 28;323(16):1582-1589</Citation><ArticleIdList><ArticleId IdType="pubmed">32219428</ArticleId></ArticleIdList></Reference><Reference><Citation>Respirology. 2018 Feb;23(2):130-137</Citation><ArticleIdList><ArticleId IdType="pubmed">29052924</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2004 Jul;10(7):676-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15214887</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 25;323(8):707-708</Citation><ArticleIdList><ArticleId IdType="pubmed">31971553</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2013 Oct;17(10):e792-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23993766</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2020 Apr;20(4):398-400</Citation><ArticleIdList><ArticleId IdType="pubmed">32113510</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Immunol. 2020 Jun;17(6):613-620</Citation><ArticleIdList><ArticleId IdType="pubmed">32203189</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Mal Infect. 2020 Jun;50(4):384</Citation><ArticleIdList><ArticleId IdType="pubmed">32240719</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2020 Apr 1;130(4):1545-1548</Citation><ArticleIdList><ArticleId IdType="pubmed">32167489</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Mar;579(7798):265-269</Citation><ArticleIdList><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Inde</li><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><country name="Inde"><noRegion><name sortKey="Venkat Kumar, G" sort="Venkat Kumar, G" uniqKey="Venkat Kumar G" first="G" last="Venkat Kumar">G. Venkat Kumar</name></noRegion><name sortKey="Jeyanthi, V" sort="Jeyanthi, V" uniqKey="Jeyanthi V" first="V" last="Jeyanthi">V. Jeyanthi</name></country><country name="États-Unis"><region name="Maryland"><name sortKey="Ramakrishnan, S" sort="Ramakrishnan, S" uniqKey="Ramakrishnan S" first="S" last="Ramakrishnan">S. Ramakrishnan</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001969 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001969 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32313660
|texte= A short review on antibody therapy for COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32313660" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |